+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Apheresis Market, By Product, By Type, By Procedure, By Technology, By End User, Estimation & Forecast, 2018-2031

  • PDF Icon

    Report

  • 215 Pages
  • July 2023
  • Region: Global
  • Astute Analytica
  • ID: 5864790
UP TO OFF until Jan 31st 2025

The global apheresis market held a market value of US$ 3.7 Billion in 2022 and is expected to grow at a CAGR of 9.12% from 2023 to 2031

The global apheresis market held a market value of US$ 3.7 Billion in 2022 and is estimated to reach US$ 7.97 Billion by the year 2031. The market is anticipated to register a CAGR of 9.12% during the forecast period.

Advances in apheresis technology, including the development of new devices and techniques, are making plasmapheresis procedures more efficient and less invasive. This is increasing patient acceptance and contributing to the growth of the market.

Growth Influencers:

Rising Prevalence of Blood Disorders
Hematological diseases significantly increase a person's risk of morbidity and mortality everywhere in the world. In May 2022 update by the CDC, sickle cell disease (SCD) affects roughly 100,000 Americans. About 1 in every 365 Black or African American infants experience it. The best method to save the life of a patient with a blood cell disorder is through early diagnosis and treatment. Therefore, the studied sector is anticipated to develop during the forecast period due to the rising burden of haematological incidences and expanding usage of apheresis as a therapy for haematological disorders.

Increasing Demand of Plasmapheresis
The increasing demand for plasmapheresis, a type of apheresis procedure that involves the removal, separation, and collection of plasma from the blood, is being driven by several factors. Autoimmune and neurological disorders, such as multiple sclerosis and myasthenia gravis, are increasing in prevalence, driving demand for plasmapheresis as a treatment option. As the global population ages, the incidence of age-related diseases such as Alzheimer's disease and dementia is increasing. This is contributing to the growing demand for plasmapheresis. Moreover, the plasma-derived therapies are used to treat a range of conditions, including bleeding disorders, immune deficiencies, and neurological disorders. The demand for these therapies is driving the need for plasmapheresis procedures to collect the plasma needed for their production.

Segments Overview:

The global apheresis market is segmented into product, type, procedure, technology, end user.

By Product
  • Apheresis Disposables
  • Apheresis Devices
The apheresis disposables segment held the highest market share of 80.2% in 2022 with the highest CAGR of 9.9% over the forecast period.

By Type

  • Plasmapheresis
  • Plateletpheresis
  • Erythrocytapheresis
  • Leukapheresis
  • Photopheresis
  • Others
The plasmapheresis segment held the highest market share of 37.6% in 2022. The segment is also the fastest growing segment with the highest CAGR of 10.9% over the forecast period.

By Procedure
  • Automated blood collection (Donor Apheresis)
  • Therapeutic Apheresis
The automated blood collection segment held the highest market share with 77.2% in 2022. In addition to that, the therapeutic apheresis segment is expected to be the fastest growing segment with a rate of 10.4% over the forecast period.

By Technology

  • Centrifugation
  • Membrane Separation
  • Selective Adsorption
The centrifugation segment held the highest market share of 67.5% in 2022 with the highest CAGR of 10.1% over the forecast period.

By End User

  • Hospital
  • Blood Collection Center
The blood collection center segment held the highest market share of 69.1% in 2022, with the highest CAGR of 10.0% over the anticipated period.

Regional Overview
By region, the global apheresis market is divided into North America, Asia Pacific, Europe, and rest of the world. The North American market for apheresis is divided into the US, Canada, and Mexico.

Moreover, the European apheresis market is segmented into the UK, Germany, France, Italy, Spain, Poland, Russia, and rest of Europe. The North American market for apheresis held the largest market share of more than 31.5% in 2022. The Asia-Pacific market for bio-based chemicals is divided into China, India, Japan, Australia and New Zealand, South Korea, ASEAN, and rest of Asia Pacific. The Asia Pacific market is supposed to be the fastest growing with a CAGR of more than 11% over the anticipated period. Furthermore, the rest of the world region is divided into GCC, South Africa, Brazil, Argentina, and rest of Middle East and South Africa.

Competitive Landscape

The key players operating in the global apheresis market include B. Braun SE, Asahi Kasei Kuraray Medical Co., Ltd., Charles River Laboratories, Fresenius SE & Co. KGAA and Terumo Corporation, and others. The cumulative market share of top four players is around 40%. For instance, Asahi Kasei Medical purchased Bionova Scientific, LLC in June 2022, which offered biopharmaceutical companies contract process development services and GMP-compliant contract manufacturing services. By combining its current businesses in bioprocess consumables, equipment, and biosafety testing services with Bionova Scientific's biologics CDMO company, Asahi Kasei Medical hopes to offer biopharmaceutical firms even more value and greater customer satisfaction.

The global apheresis market report provides insights on the below pointers:

  • Market Penetration: Provides comprehensive information on the market offered by the prominent players
  • Market Development: The report offers detailed information about lucrative emerging markets and analyzes penetration across mature segments of the markets
  • Market Diversification: Provides in-depth information about untapped geographies, recent developments, and investments
  • Competitive Landscape Assessment: Mergers & acquisitions, certifications, product launches in the global apheresis market have been provided in this research report. In addition, the report also emphasizes the SWOT analysis of the leading players.
  • Product Development & Innovation: The report provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
  • Pricing Analysis: Pricing analysis of various components used in the manufacturing
  • Manufacturing Cost Analysis: Cost-share of various components in apheresis, cost analysis of apheresis, unit cost analysis of apheresis

Apheresis Market Overview

  • Guidelines on the Use of Therapeutic Apheresis in Clinical Practice

The global apheresis market report answers questions such as:

  • What is the market size and forecast of the global apheresis market?
  • What are the inhibiting factors and impact of COVID-19 on the global apheresis market during the assessment period?
  • Which are the products/segments/applications/areas to invest in over the assessment period in the global apheresis market?
  • What is the competitive strategic window for opportunities in the global apheresis market?
  • What are the technology trends and regulatory frameworks in the global apheresis market?
  • What is the market share of the leading players in the global apheresis market?
  • What modes and strategic moves are considered favorable for entering the global apheresis market?

Table of Contents

Chapter 1. Research Framework
1.1 Research Objective
1.2 Product Overview
1.3 Market Segmentation
Chapter 2. Research Methodology
2.1 Qualitative Research
2.1.1 Primary & Secondary Sources
2.2 Quantitative Research
2.2.1 Primary & Secondary Sources
2.3 Breakdown of Primary Research Respondents, By Region
2.4 Assumption for the Study
2.5 Market Size Estimation
2.6. Data Triangulation
Chapter 3. Executive Summary: Global Apheresis Market
Chapter 4. Global Apheresis Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Material Provider
4.1.2. Manufacturer
4.1.3. Service Providers
4.1.4. End Users
4.2. Industry Outlook
4.2.1. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends
4.6. Covid-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2018 - 2031
4.7.2. Pricing Analysis
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2022
4.8.3. Competitor Mapping
Chapter 5. Global Apheresis Market Analysis, By Product
5.1. Key Insights
5.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
5.2.1. Apheresis Disposables
5.2.2. Apheresis Devices
Chapter 6. Global Apheresis Market Analysis, By Type
6.1. Key Insights
6.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
6.2.1. Plasmapheresis
6.2.2. Plateletpheresis
6.2.3. Erythrocytapheresis
6.2.4. Leukapheresis
6.2.5. Photopheresis
6.2.6. Other
Chapter 7. Global Apheresis Market Analysis, By Procedure
7.1. Key Insights
7.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
7.2.1. Automated blood collection (Donor Apheresis)
7.2.2. Therapeutic Apheresis
Chapter 8. Global Apheresis Market Analysis, By Technology
8.1. Key Insights
8.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
8.2.1. Centrifugation
8.2.2. Membrane Separation
8.2.3. Selective Adsorption
Chapter 9. Global Apheresis Market Analysis, By End User
9.1. Key Insights
9.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
9.2.1. Hospital
9.2.2. Blood Collection Center
Chapter 10. Global Apheresis Market Analysis, By Region
10.1. Key Insights
10.2. Market Size and Forecast, 2018 - 2031 (US$ Mn & Mn Units)
10.2.1. North America
10.2.1.1. The U.S.
10.2.1.2. Canada
10.2.2. Europe
10.2.2.1. Western Europe
10.2.2.1.1. The UK
10.2.2.1.2. Germany
10.2.2.1.3. France
10.2.2.1.4. Italy
10.2.2.1.5. Spain
10.2.2.1.6. Rest of Western Europe
10.2.2.2. Eastern Europe
10.2.2.2.1. Poland
10.2.2.2.2. Russia
10.2.2.2.3. Rest of Eastern Europe
10.2.3. Asia Pacific
10.2.3.1. China
10.2.3.2. India
10.2.3.3. Japan
10.2.3.4. South Korea
10.2.3.5. Australia & New Zealand
10.2.3.6. ASEAN
10.2.3.10. Rest of Asia Pacific
10.2.4. Middle East & Africa
10.2.4.1. UAE
10.2.4.2. Saudi Arabia
10.2.4.3. South Africa
10.2.4.4. Rest of MEA
10.2.5. South America
10.2.5.1. Argentina
10.2.5.2. Brazil
10.2.5.3. Rest of South America
Chapter 11. North America Apheresis Market Analysis
11.1. Key Insights
11.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
11.2.1. By Product
11.2.2. By Type
11.2.3. By Procedure
11.2.4. By Technology
11.2.5. By End User
11.2.6. By Country
Chapter 12. Europe Apheresis Market Analysis
12.1. Key Insights
12.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
12.2.1. By Product
12.2.2. By Type
12.2.3. By Procedure
12.2.4. By Technology
12.2.5. By End User
12.2.6. By Country
Chapter 13. Asia Pacific Apheresis Market Analysis
13.1. Key Insights
13.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
13.2.1. By Product
13.2.2. By Type
13.2.3. By Procedure
13.2.4. By Technology
13.2.5. By End User
13.2.6. By Country
Chapter 14. Middle East and Africa Apheresis Market Analysis
14.1. Key Insights
14.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
14.2.1. By Product
14.2.2. By Type
14.2.3. By Procedure
14.2.4. By Technology
14.2.5. By End User
14.2.6. By Country
Chapter 15. South America Apheresis Market Analysis
15.1. Key Insights
15.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
15.2.1. By Product
15.2.2. By Type
15.2.3. By Procedure
15.2.4. By Technology
15.2.5. By End User
15.2.6. By Country
Chapter 16. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
16.1. Asahi Kasei Medical Co. Ltd.
16.2. B. Braun Melsungen AG
16.3. Baxter International Inc.
16.4. Cerus Corporation
16.5. Charles River Laboratories International, Inc.
16.6. Haemonetics Corporation
16.7. Kaneka Corporation
16.8. Kawasumi Laboratories Inc
16.9. Nikkiso Co., Ltd.
16.10. Terumo BCT, Inc
16.11. Fresenius Kabi
16.12. Other Prominent Players

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Cerus Corporation
  • Charles River Laboratories International, Inc.
  • Haemonetics Corporation
  • Kaneka Corporation
  • Kawasumi Laboratories Inc
  • Nikkiso Co., Ltd.
  • Terumo BCT, Inc
  • Fresenius Kabi

Table Information